Der Einfluss von Unterschieden zwischen Patientengruppen und von sozioökonomischen Ungleichheiten bei der Brustkrebsbehandlung
![Monique Gary, MD]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1267-awareness-for-patient-group-differences-in-breast-cancer-treatment/monique_gary.jpg/_jcr_content/renditions/original.image_file.100.100.file/monique_gary.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1267-awareness-for-patient-group-differences-in-breast-cancer-treatment/monique_gary.jpg/_jcr_content/renditions/original.image_file.360.360.file/monique_gary.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1267-awareness-for-patient-group-differences-in-breast-cancer-treatment/monique_gary.jpg/_jcr_content/renditions/original.image_file.768.768.file/monique_gary.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1267-awareness-for-patient-group-differences-in-breast-cancer-treatment/monique_gary.jpg/_jcr_content/renditions/original./monique_gary.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1267-awareness-for-patient-group-differences-in-breast-cancer-treatment/monique_gary.jpg/_jcr_content/renditions/original./monique_gary.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1267-awareness-for-patient-group-differences-in-breast-cancer-treatment/monique_gary.jpg/_jcr_content/renditions/original./monique_gary.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1267-awareness-for-patient-group-differences-in-breast-cancer-treatment/monique_gary.jpg/_jcr_content/renditions/original./monique_gary.jpg"} "Monique Gary, MD")
Der Einfluss von Unterschieden zwischen Patientengruppen und von sozioökonomischen Ungleichheiten bei der Brustkrebsbehandlung
Monique Gary erörtert den Einfluss von Unterschieden zwischen Patientengruppen und von sozioökonomischen Ungleichheiten bei der Brustkrebsbehandlung aus ihrer Sicht als Fachärztin für chirurgische Krebsheilkunde für Frauen.
Zu Beginn stellt sie kurz das Thema Brustkrebs vor und erläutert die typischen vermeidbaren und unvermeidbaren Risikofaktoren für Brustkrebs und die Unterschiede zwischen normalen Patienten und Risikopatienten. Danach beleuchtet sie die Rolle des ethnischen Hintergrunds und den Einfluss sozioökonomischer Faktoren auf die Prävalenz, Diagnose und Behandlung von Brustkrebs anhand von eindrucksvollen Beispielen und Berichten aus ihrer klinischen Praxis. Zusätzlich beschreibt sie die heutige Situation in der Brustkrebsversorgung angesichts der Ungleichheiten sowie die in Zukunft nötigen Verbesserungen.
![Situation in der Evidenz/den Leitlinien hinsichtlich der Diversifikation und Patientenbedürfnisse bei der Brustkrebsbehandlung]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1268-awareness-on-how-evidence-guidelines-reflect-diversity-and-patient-needs-in-breast-cancer-treatments/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg/_jcr_content/renditions/original.image_file.100.56.file/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1268-awareness-on-how-evidence-guidelines-reflect-diversity-and-patient-needs-in-breast-cancer-treatments/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg/_jcr_content/renditions/original.image_file.360.203.file/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1268-awareness-on-how-evidence-guidelines-reflect-diversity-and-patient-needs-in-breast-cancer-treatments/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg/_jcr_content/renditions/original.image_file.768.432.file/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1268-awareness-on-how-evidence-guidelines-reflect-diversity-and-patient-needs-in-breast-cancer-treatments/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg/_jcr_content/renditions/original./1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1268-awareness-on-how-evidence-guidelines-reflect-diversity-and-patient-needs-in-breast-cancer-treatments/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg/_jcr_content/renditions/original./1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1268-awareness-on-how-evidence-guidelines-reflect-diversity-and-patient-needs-in-breast-cancer-treatments/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg/_jcr_content/renditions/original./1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/1268-awareness-on-how-evidence-guidelines-reflect-diversity-and-patient-needs-in-breast-cancer-treatments/1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg/_jcr_content/renditions/original./1268-en-int-30-160-0577i-breast-cancer-awareness-month-2022-interview-eileen-connolly_teaser.jpg"} "Situation in der Evidenz/den Leitlinien hinsichtlich der Diversifikation und Patientenbedürfnisse bei der Brustkrebsbehandlung")
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.100.56.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.360.203.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.768.432.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1024.576.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1280.720.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-pedro-lara-breast-cancer-radiation-preview.png/_jcr_content/renditions/original.image_file.1365.768.1,0,1366,768.file/626-pedro-lara-breast-cancer-radiation-preview.png"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.100.56.79,35,1331,739.file/627-sperk-targit-a-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.360.203.79,35,1331,739.file/627-sperk-targit-a-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.768.432.79,35,1331,739.file/627-sperk-targit-a-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1024.576.79,35,1331,739.file/627-sperk-targit-a-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png"})